Sutter Health Research Enterprise
795 El Camino Real
Lee Building, Level A
Palo Alto, CA, 94301
(650) 853-2905
ColoccN1@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Adjuvant (AFT-19)
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Investigators: Priya Chakravarthi M.D., M. Dwight Chen M.D., Natalia Colocci M.D., Ph.D., Huan T. Ha M.D., Gillian L. Hsieh M.D., Paula D. Kushlan M.D., David S. Leibowitz M.D., FACP, Kim-Son Nguyen M.D., Albert Pisani M.D., Bryant C. Sheh M.D., Edmund W. Tai M.D., Janet Wang M.D., Derrick Wong M.D., Glenn D. Wong D.O., Irene Wu M.D., Michael C. Wu M.D., Monique de Bruin M.D., MPH
Status: Active, Not Recruiting
The Pathfinder 2 Study (Grail)
Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population
Investigators: Roger Ang MD, Deepti Behl MD, Kristie A. Bobolis M.D., Carole Chan-You M.D., Natalia Colocci M.D., Ph.D., Natasha Fine M.D., Mohammad Hararah M.D., Aaron Kinney M.D., Charles McDonnell MD, FACR, Patrick Ogilvie M.D., Sivakumar Reddy M.D., Nitin Rohatgi MD, Barbara Spinelli M.D., Gayle Sutcliffe M.D., Edmund W. Tai M.D.
Status: Active, Not Recruiting
Publications
Evolving goals of care discussions as described in interviews with individuals with advanced cancer and oncology and palliative care teams.
Frequency, quality, and content of care conversations were shaped by pt receptivity, stage of illness, clinician attitudes, predispositions to palliative care.